```json
{
"content": [
{
"type": "paragraph",
"content": "Microwave Ablation Therapy is segmented by Application and Types. The Application category is dominated by Tumor Treatment, accounting for 65% of the market, driven by high adoption in oncology for liver, lung, and kidney tumors. Cardiac Ablation (35%) addresses arrhythmia management, with procedural advancements boosting demand. The Types segment includes Tissue Ablation (e.g., solid tumors, soft tissue lesions) and Coagulation (e.g., hemostasis, vascular occlusion), with Tissue Ablation leading due to its broad application in cancer care. This Microwave Ablation Therapy and Multimodal Evaluation System segmentation highlights oncology as the primary growth driver, while coagulation supports surgical applications. Type-specific innovations, such as precise thermal control in Tissue Ablation, further enhance market differentiation."
},
{
"type": "paragraph",
"content": "Multimodal Evaluation System is segmented by Application and Types. The Application segment is led by Preoperative Planning (50%), which integrates imaging and simulation for complex surgeries, followed by Real-Time Monitoring (30%) in intraoperative guidance and Postoperative Assessment (20%) for recovery tracking. Types include Diagnostic Imaging (e.g., MRI, CT, ultrasound) and Therapeutic Guidance (e.g., image-guided surgery, radiation therapy), with Diagnostic Imaging dominating due to its role in early disease detection. This segmentation underscores the market taxonomy of precision medicine, where diagnostic tools account for 60% of the market share, while therapeutic guidance gains traction in oncology and neurology. Application diversity ensures robust growth in both diagnostic and interventional domains."
}
],
"chartData": {
"segments": [
{ "name": "Tumor Treatment", "value": 65 },
{ "name": "Cardiac Ablation", "value": 35 }
]
}
}
```
